实体特征和治疗模式在基本血小板血:一个基于人口的横截面研究在台湾在2020年和2021年之间
Ming-Sun Yu1, Lennex Hsueh-Lin Yu2, Shih-Hao Huang3
1Division of Hematology, Conde S. Januário Hospital, Macau, China.
Therapeutic advances in hematology
|July 30, 2025
概括
基本血小板血 (ET) 在台湾造成严重的健康负担,年轻患者经历了高血小板血复发率,尽管治疗. 目前的治疗模式需要优化,以获得更好的患者结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 流行病学 流行病学
背景情况:
- 基本血小板血 (ET) 是一种骨髓增殖性瘤,其特点是血小板数量高,并增加了血栓形成和出血的风险.
- 了解ET人口统计,治疗模式和血栓复发对于患者管理至关重要.
研究的目的:
- 调查ET的台湾患者的人口统计,治疗模式和复发性血栓形成风险.
- 分析特定年龄的治疗策略及其对血栓复发的影响.
主要方法:
- 一项基于人口的横截面研究,使用台湾国家健康保险研究数据库 (2020-2021).
- 使用ICD-10-CM代码识别ET患者;分析了人口统计,临床和治疗数据.
- 进行了描述性和统计分析,以评估患者的特征,治疗方法和血栓事件复发率.
主要成果:
- 该研究包括4503名ET患者 (患病率19.3/100,000),平均年龄为58.1岁,女性占主导 (60.3%).
- 血栓形成发生在3.8%的患者中;30.5%的患者出现了复发. 年轻的患者接受了更高的剂量,但复发率更高.
- 二次性骨髓纤维化和急性骨髓性白血病的累积发病率分别为2.6%和0.6%在2年内.
结论:
- ET在台湾是一个巨大的负担,对血栓形成的预防有着未得到满足的需求,特别是对年轻人来说.
- 现实世界中的治疗模式偏离了指导方针,需要个性化策略以获得最佳结果.
- 需要进一步进行纵向研究,以探索ET患者的血栓形成风险因素,疾病进展和死亡率.
相关概念视频
Erythropoiesis
4.8K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.8K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
259
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
259
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Venous Thrombosis IV: Nursing Management
24
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
24
Disorders of Hemostasis
1.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.2K


